Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Psychosomatics
- Vol. 61 (3) , 302-306
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001436, KL2TR001438)
This publication has 20 references indexed in Scilit:
- Posterior Reversible Encephalopathy Syndrome (PRES) Following Disulfiram Intoxication - A Case ReportIndian Journal of Public Health Research & Development, 2013
- Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic IllnessPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2012
- Disulfiram reaction in an artist exposed to solventsOccupational Medicine, 2011
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like propertiesBritish Journal of Cancer, 2011
- Posterior reversible encephalopathy syndrome following disulfiram intoxicationJournal of Neurology, 2011
- Posterior Reversible Encephalopathy Syndrome: Associated Clinical and Radiologic FindingsMayo Clinic Proceedings, 2010
- Effects of dopamine β-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in micePsychopharmacology, 2005
- Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma CellsJournal of Medicinal Chemistry, 2004
- Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mappingNeuroradiology, 2004
- Can Dopamine Beta‐Hydroxylase Levels Predict Adverse Reactions to Disulfiram?Alcohol, Clinical and Experimental Research, 1978